Collaborate Disseminate
It’s estimated that 27.5% of people globally are affected by pain. While they might be effective, existing analgesics each have their issues. Acetaminophen/paracetamol (Tylenol, Panadol) can be toxic to the liver, and non-steroidal anti-inflammatory dr… Continue reading New non-toxic analgesic provides hope to nerve pain sufferers
Scientists have developed a promising new drug that could prevent and even reverse the onset of type 1 diabetes. The experimental monoclonal antibody drug acts like a shield to protect insulin-producing cells from damage, even extending lifespan in som… Continue reading Experimental antibody drug prevents and even reverses diabetes onset
“As people live longer, improving quality of life is paramount,” said Alex Morgan, a partner at Khosla Ventures, who chipped in to fund Rubedo’s first round of venture capital financing. “Rubedo is targeting senescent, or aging, cells that drive age-re… Continue reading Anti-aging biopharma company raises $40 million to begin human tests
If you’ve ever caught the flu, you’ve more than likely been infected with the Influenza A virus (IAV). Compared to the Influenza B virus, infection with the A type often produces more severe symptoms. But, while many of us have experienced the fever an… Continue reading New flu drug aims to keep you in a ‘Goldilocks zone’ of lung inflammation
If you’ve ever caught the flu, you’ve more than likely been infected with the Influenza A virus (IAV). Compared to the Influenza B virus, infection with the A type often produces more severe symptoms. But, while many of us have experienced the fever an… Continue reading New flu drug aims to keep you in a ‘Goldilocks zone’ of lung inflammation
Manufacturing the groundbreaking and extremely popular diabetes and weight-loss drug semaglutide – Ozempic, Wegovy – is a complex, slow process. Amid ongoing global shortages, researchers have developed a cheaper, faster method that produces ten times … Continue reading Global Ozempic shortage fix: Cheaper, faster method produces 10x more
A new study has found that a compound created by the body’s breakdown of a cancer drug has therapeutic properties. When combined with the original drug, the by-product produced a synergistic effect to inhibit prostate cancer cells; when used alone, it reduced the buildup of a toxic protein in the brain associated with Parkinson’s disease.
Tags: metabolism, Drug, Prostate cancer, Parkinson’s Disease
Continue reading Cancer drug by-product may be an untapped Parkinson’s treatment
A new study has found that a compound created by the body’s breakdown of a cancer drug has therapeutic properties. When combined with the original drug, the by-product produced a synergistic effect to inhibit prostate cancer cells; when used alone, it reduced the buildup of a toxic protein in the brain associated with Parkinson’s disease.
Tags: metabolism, Drug, Prostate cancer, Parkinson’s Disease
Continue reading Cancer drug by-product may be an untapped Parkinson’s treatment
With the world in an opioid crisis, the development of non-opioid analgesics has become more urgent. A series of Phase 3 clinical trials into a novel oral, non-opioid painkiller has found that it’s effective in treating acute pain in both surgical and … Continue reading Non-opioid proves effective for acute surgical & non-surgical pain
White blood cells are important foot soldiers in the immune system, but their numbers can be cut by health conditions or treatments like chemotherapy. Yale scientists have now discovered a molecule that can be given to quickly boost their numbers back … Continue reading New molecule triggers burst of white blood cells to fight infections